MedtronicNeuro
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, MedtronicNeuro sits in the top decile of US sponsors by registered trial count (#372 of 15,742 sponsors by registered trial count).
MedtronicNeuro: 51 sponsored US clinical trials, 2 recruiting.
MedtronicNeuro sponsors 51 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 36 completed. 8 of these trials are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Chronic Pain, with 3 trials.
Top-decile sponsor footprint
MedtronicNeuro ranks in the top decile of sponsors by registered trial count (#372 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
36 of 48 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (75.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
51 total, page 1 of 2
Post Approval Effectiveness and Durability Evaluation of the Altaviva™ Tibial Device
NCT07456865
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
NCT05200923
Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)
NCT03900468
Study to Evaluate Neuromodulation Subject Experience With Contemporary Spinal Cord Stimulation (SCS) Modalities for Chronic Pain
NCT05775510
Evaluation of Implantable Tibial Neuromodulation Pivotal Study (TITAN 2)
NCT05226286
Evaluation of Implantable Tibial Neuromodulation (TITAN 1) Feasibility Study
NCT04873271
Electrically Evoked Compound Action Potentials Human Observation Medtronic Algorithm Comparison Study
NCT04765735
Adaptive DBS Algorithm for Personalized Therapy in Parkinson's Disease
NCT04547712
DTM (TM) Spinal Cord Stimulation (SCS) Study
NCT04601454
InterStim Micro Post Market Clinical Follow-up Study (ELITE)
NCT04506866
InterStim Basic Evaluation Lead Post-Market Clinical Follow-up Study
NCT04016324
Electrically Evoked Compound Action Potentials Human Observation Medtronic System Study (ECHO-MDT)
NCT06499220
Embrace TDD: Post-Market Study to Evaluate Intrathecal Morphine as an Alternative to Systemic Opioids for Chronic Pain
NCT03761277
SCS Research Study
NCT03763708
LFP Beta aDBS Feasibility Study
NCT03446833
Visualase Visualization Database (VIVID-1)
NCT03489187
InterStim® Amplitude Study
NCT03335761
Vectors Post Market: A Study to Assess Pain Relief Using Spinal Cord Stimulation
NCT03345472
Spinal Cord Stimulation (SCS) Dosing Study
NCT03284411
OsteoCool Tumor Ablation Post-Market Study
NCT03249584
Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)
NCT02844465
PRospective Study to Evaluate EffectivenesS With the NURO™ PErcutaneous Tibial Neuromodulation System in Patients With OAB
NCT02857816
OPTIONS Spinal Cord Stimulation Programming Parameters
NCT02503787
Intrathecal Morphine Compared to Conventional Medical Management for Pain Control and Opioid-related Side Effects
NCT01924182
InterStim® Sacral Nerve Modulation Cycling Study
NCT01957137
Subcutaneous Nerve Stimulation for Failed Back Surgery Syndrome (FBSS) Patients
NCT01818297
Spinal Cord Stimulation for Predominant Low Back Pain
NCT01697358
Retrospective, Non-significant Risk, Deep Brain Stimulation (DBS) Care Management Software Feasibility Study
NCT01750242
Epilepsy Motion Sensing
NCT01850498
Measuring Signatures in the Fluid Surrounding the Spinal Cord in Patients Who Have Problems With Intrathecal Drug Delivery
NCT01117090
RestoreSensor Study
NCT01106404
InterStim Therapy Programming Study
NCT01009333
SISTERS: Spasticity In Stroke Study - Randomized Study
NCT01032239
RECHARGE Sub-Study to the Implantable Systems Performance Registry (ISPR)
NCT00998660
Reclaim Deep Brain Stimulation Clinical Study for Treatment-Resistant Depression
NCT00837486
Spinal Cord Stimulation Research Study
NCT00768872
Spinal Cord Stimulation Research Study
NCT00737581
A Safety and Effectiveness Study of Intraspinal Gabapentin (MDT2004) for the Treatment of Chronic Pain
NCT00414466
A Cost Analysis of Interstim Therapy
NCT00200031
Study of Weight Loss Using Gastric Stimulation in Obese Patients With Type 2 Diabetes
NCT00200018
Restore Claims Characterization Study
NCT00200122
Patient Registry to Study the Tined Lead Used With the InterStim System For Urinary Control
NCT00225966
Occipital Nerve Stimulation for the Treatment of Chronic Migraine Headache.
NCT00200109
Study of Weight Loss Using Gastric Stimulation in Obese Patients
NCT00200083
Implantable Systems Performance Registry
NCT00959296
Neurostimulation to Treat Refractory Angina Pectoris Pain
NCT00200070
An Evaluation of the Medtronic Gatekeeper System in the Treatment of SUBJECTS With Gastroesophageal Reflux Disease (GERD)
NCT00200044
Enterra Therapy Clinical Study (Gastric Stimulation for Gastroparesis)
NCT00157755
Sacral Nerve Stimulation Therapy for the Treatment of Chronic Fecal Incontinence
NCT00200057
Sacral Nerve Stimulation for Anal Incontinence and Bowel Control
NCT00200005
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 2 |
| Phase 3 | 1 |
| Phase 4 | 7 |
Therapeutic Areas
Where MedtronicNeuro enrollment is open (later-stage tilt)
2 recruiting of 51 indexed (4% open); 36 completed (71%).
Phase mix: 8 late (III/IV) vs 3 early (I/II) (later-stage heavy).
Top condition: Chronic Pain (3 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
MedtronicNeuro: open-pipeline peers nationwide
Peers matched on 51 registered trials and 4% open enrollment, not the therapeutic-area sidebar.
MedtronicNeuro sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 51 trials (± recruiting share)
- Colgate Palmolive · 51 trials · 6% recruiting
- Ohio University · 51 trials · 10% recruiting
- Reproductive Medicine Associates of New Jersey · 51 trials · 14% recruiting
- Texas Woman's University · 51 trials · 6% recruiting
Sponsors near 4% open enrollment (± trial volume)
- Celgene · 4% recruiting · 308 trials
- U.S. Army Medical Research and Development Command · 4% recruiting · 77 trials
- Aldeyra Therapeutics · 4% recruiting · 26 trials
- DexCom · 4% recruiting · 26 trials
Related
What to do with this MedtronicNeuro page
51 registered trials is a research-attention snapshot, not an endorsement of MedtronicNeuro or any single study.
- 2 of MedtronicNeuro's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Chronic Pain is the condition MedtronicNeuro studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
MedtronicNeuro pipeline card: 51 registered trials from official public datasets.Report a data error.